Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
A study of the once-weekly investigational dipeptidyl peptidase-4 omarigliptin reported a clinically meaningful reduction in glycated hemoglobin that was maintained throughout the study.